نتائج البحث - "Cindy Oh"

1

دورية أكاديمية

Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trialResearch in context

المؤلفون: Tanios Bekaii-Saab, Takuji Okusaka, David Goldstein, Do-Youn Oh, Makoto Ueno, Tatsuya Ioka, Weijia Fang, Eric C. Anderson, Marcus S. Noel, Michele Reni, Hye Jin Choi, Jonathan S. Goldberg, Sang Cheul Oh, Chung-Pin Li, Josep Tabernero, Jian Li, Emma Foos, Cindy Oh, Eric Van Cutsem

المصدر: EClinicalMedicine, Vol 58, Iss , Pp 101897- (2023)

مصطلحات موضوعية: Napabucasin, Pancreatic cancer, Adenocarcinoma, Metastatic pancreatic adenocarcinoma, Phosphorylated signal transducer and activator of transcription 3, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2589537023000743; https://doaj.org/toc/2589-5370

URL الوصول: https://doaj.org/article/5dbeea00320a4570827b5add5de5eb9c

View record from ScienceDirect

Full Text via ClinicalKey

Full Text Finder

2

Cindy Oh Cindy

المؤلفون: Cindy Oh Cindy (Performer)

المصدر: The Orchard
http://www.theorchard.com/

URL الوصول: http://europeana.eu/portal/record/2023601/oai_eu_dismarc_HIGH_USA560643036.html

3

Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

المصدر: Clinical Cancer Research. 28:3686-3694

مصطلحات موضوعية: EXPRESSION, GROWTH-FACTOR, Cancer Research, Science & Technology, CARCINOMA, UNITED-STATES, 2ND-LINE CHEMOTHERAPY, OPEN-LABEL, COLORECTAL-CANCER, Oncology, CLINICOPATHOLOGICAL FEATURES, SURVIVAL, COMBINATION, Life Sciences & Biomedicine

وصف الملف: Print-Electronic

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f89d13bc9b211532274291e1bf31301
https://doi.org/10.1158/1078-0432.ccr-21-4021

4

Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial

المؤلفون: Tanios Bekaii-Saab, Takuji Okusaka, David Goldstein, Do-Youn Oh, Makoto Ueno, Tatsuya Ioka, Weijia Fang, Eric C. Anderson, Marcus S. Noel, Michele Reni, Hye Jin Choi, Jonathan S. Goldberg, Sang Cheul Oh, Chung-Pin Li, Josep Tabernero, Jian Li, Emma Foos, Cindy Oh, Eric Van Cutsem

المساهمون: Institut Català de la Salut, [Bekaii-Saab T] Division of Hematology and Medical Oncology, Mayo Clinic Arizona, Scottsdale, AZ, USA. [Okusaka T] Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan. [Goldstein D] Department of Medical Oncology, Prince of Wales Hospital, Randwick, NSW, Australia. [Oh DY] Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Republic of Korea. [Ueno M] Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, Kanagawa, Japan. [Ioka T] Oncology Center, Yamaguchi University Hospital, Yamaguchi, Japan. [Tabernero J] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB-Quiron, UVic-UCC, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Pancreatic Neoplasms [DISEASES], Otros calificadores::/uso terapéutico [Otros calificadores], Metastatic pancreatic adenocarcinoma, terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Medicaments antineoplàstics - Ús terapèutic, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], General Medicine, Pancreatic cancer, Adenocarcinoma, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Phosphorylated signal transducer and activator of transcription 3, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Pàncrees - Càncer - Tractament, Avaluació de resultats (Assistència sanitària), Other subheadings::/therapeutic use [Other subheadings], neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias pancreáticas [ENFERMEDADES], Napabucasin